510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K251289Substantially Equivalent

WELLlife COVID-19 Antigen Test Rx

Guangzhou Wondfo Biotech Co., Ltd., Guangzhou, CN / Dual Track, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K251289 is the FDA 510(k) clearance record for WELLlife COVID-19 Antigen Test Rx, a class II device, cleared for Guangzhou Wondfo Biotech Co., Ltd. on under FDA product code QVF (Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings). FDA's definition for product code QVF reads: "A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an...". FDA records list 43 510(k) clearances for Guangzhou Wondfo Biotech Co., Ltd., from to . As of , FDA records show no recalls naming K251289.

Clearance record

Decision date
Received
(180 days to decision)
Product code
QVF Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Regulation
21 CFR 866.3982
Device class
Class II
Review panel
Microbiology
Applicant
Guangzhou Wondfo Biotech Co., Ltd. #8 Lizhishan Rd., Science City, Huangpu District, Guangzhou, CN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QVF

Trailing 12 months
2 clearances under product code QVF in the twelve months to October 2026, June 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code QVF, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20261
July 20260
August 20260
September 20261
October 20260